Circulating Tumor Cells and Radiotherapy Benefit in Early Breast Cancer—Reply

In Reply We thank Drs Tsoutsou and Vozenin for their insightful comments regarding our recent article detailing the potential for using circulating tumor cell (CTC) status as a predictive biomarker for benefit of radiotherapy among patients with early-stage breast cancer.

https://ift.tt/2S6r5RI